SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-18-000929
Filing Date
2018-06-14
Accepted
2018-06-14 16:00:21
Documents
9
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 form3-06142018_040602.html 3  
1 form3-06142018_040602.xml 3 34537
2 ex24-06142018_040603.htm EX-24 4713
3 ex99-06142018_040604.htm EX-99 3982
4 graphic-06132018_090647.jpg GRAPHIC 239000
5 graphic-06132018_090648.jpg GRAPHIC 230702
6 graphic-06132018_090649.jpg GRAPHIC 216765
7 graphic-06132018_090650.jpg GRAPHIC 378347
8 graphic-06132018_090651.jpg GRAPHIC 377760
9 graphic-06132018_090652.jpg GRAPHIC 127128
  Complete submission text file 0001415889-18-000929.txt   2207177
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
AHMED NADIM (Reporting) CIK: 0001731193 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34912 | Film No.: 18899138